StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingApr 15, 2026, 04:06 PM

GeoVax Labs Files 10-K; Reports 2.89M Shares Outstanding

AI Summary

GeoVax Labs, Inc. filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The filing disclosed 2,892,570 shares of common stock outstanding as of April 15, 2026. Additionally, the aggregate market value of common stock held by non-affiliates was reported as $13,723,592 as of June 30, 2025.

Key Highlights

  • Filed annual report Form 10-K for fiscal year ended December 31, 2025.
  • Reported 2,892,570 common shares outstanding as of April 15, 2026.
  • Non-affiliate market value was $13,723,592 as of June 30, 2025.